FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20220708E00515
1. Date of relevant event: 05/07/2022
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 01167
4. Name of listed corporation: Jacobio Pharmaceuticals Group Co., Ltd. - B 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 771,462,180
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Wang
(Other names) Yinxiang
10. Name of director (Chinese): 王印祥 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1211The number of shares in which you are interested has reduced because:
you have ceased to be a member of a concert party group or a member of the concert party group has disposed of some of the shares
 
2501Other (you must describe the capacity in the Supplementary Information box)
 
 		 3,000,000  HKD  6.0000  6.0000   
 
Short position 
 
 
 		            
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position223,483,65028.97
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position220,483,65028.58
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2201Interest of corporation controlled by you
Long position131,820,000
2501Other (you must describe the capacity in the Supplementary Information box)
Long position88,663,650
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
           
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
Willgenpharma LtdCraigmuir Chambers, Road Town, Tortola VG1110, British Virgin IslandsYinxiang Wang24.84Y
Long position30,590,000
Yakovpharma LtdCraigmuir Chambers, Road Town, Tortola VG1110, British Virgin IslandsYinxiang Wang100.00Y
Long position62,855,000
Johwpharma LtdCraigmuir Chambers, Road Town, Tortola VG1110, British Virgin IslandsYinxiang Wang86.00Y
Long position36,875,000
Honourpharma LtdCraigmuir Chambers, Road Town, Tortola VG1110, British Virgin IslandsYinxiang Wang100.00Y
Long position1,500,000
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
Xiaojie WangAddresses of individuals are not displayed.
Long position220,483,650
Risepharma LtdAddresses of individuals are not displayed.
Long position220,483,650
Gloryviewpharma LtdAddresses of individuals are not displayed.
Long position220,483,650
Blesspharma LtdAddresses of individuals are not displayed.
Long position220,483,650
Yunyan HuAddresses of individuals are not displayed.
Long position220,483,650
Hmed LtdAddresses of individuals are not displayed.
Long position220,483,650
Wordspharma LtdAddresses of individuals are not displayed.
Long position220,483,650
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: Box 24: Risepharma Ltd, the corporation controlled by Ms. Xiaojie Wang, completed a sale of 3,000,000 shares on public market. Box 27: Yinxiang Wang and the shareholders listed in Boxes 30 and 31 are concert parties, each deemed interested in aggregate interests of 220,483,650 shares, including the shares owned by Wordspharma Ltd, which is wholly owned by Zhu Shen, Yinxiang Wang's wife.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 08/07/2022
(dd/mm/yyyy)